Procainamide Hydrochloride (McKesson Packaging Services Business Unit of McKesson Corporation)


Welcome to the PulseAid listing for the Procainamide Hydrochloride drug offered from McKesson Packaging Services Business Unit of McKesson Corporation. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: McKesson Packaging Services Business Unit of McKesson Corporation
NON-PROPRIETARY NAME: Procainamide Hydrochloride
SUBSTANCE NAME: PROCAINAMIDE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2010-02-01
END MARKETING DATE: 0000-00-00


Procainamide Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProcainamide Hydrochloride from McKesson Packaging Services Business Unit of McKesson Corporation
LABELER NAME: McKesson Packaging Services Business Unit of McKesson Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2010-02-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63739-459_4e23837d-d376-4c8e-a94e-1ddb585dbbf7
PRODUCT NDC: 63739-459
APPLICATION NUMBER: ANDA089069

Other PROCAINAMIDE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthProcainamide Hydrochloride
Hospira, Inc.Procainamide Hydrochloride
International Medication Systems, LimitedProcainamide Hydrochloride
McKesson Packaging Services Business Unit of McKesson CorporationProcainamide Hydrochloride
Nexus Pharmaceuticals IncProcainamide Hydrochloride